Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche's New Chief Medical Officer Levi Garraway Brings Deep Cancer Genomics Expertise

Aug 19 2019

• By Jessica Merrill

Dr. Levi Garraway, Chief Medical Officer and Head of Global Product Development, Roche and Genentech — Roche's new chief medical officer Levi Garraway

Related Content

Lilly Hopes To Revitalize Its Cancer Brand With 'Foundational' Agents

Jul 25 2017

$1.6bn ARMO Buy Gives Lilly Its Most Advanced Immuno-Oncology Asset

May 11 2018

Roche's Polivy ADC Is Approved As Another New Option For R/R DLBCL

Jun 11 2019

Roche Raises Outlook Despite US Biosimilars, Sees Spark Buy By Year-End

Jul 25 2019

Lilly/Loxo Deal Came Together Quickly

Jan 17 2019

Roche Pushes Personalization With $2.4bn Foundation Buy-Out

Jun 19 2018

Roche’s Pipeline Prospects Promise Steady Sailing To More Growth

Aug 01 2019

Roche/Genentech Set Lower Rozlytrek Price To Catch Up With Bayer’s Vitrakvi

Aug 16 2019

Related Companies

Roche Holding AG

Eli Lilly and Company

ARMO BioSciences, Inc.

Loxo Oncology at Lilly

Foundation Medicine, Inc.

AbbVie Inc.

Bayer AG

Spark Therapeutics, Inc.

Additional Topics

Leadership Companies Cancer

More from Leadership

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window